Trials / Completed
CompletedNCT04171349
Articaine vs Dexmedetomidine Supplemented Articaine
Articaine and Dexmedetomidine - Supplemented Articaine for Arteriovenous Fistula Creation Under Ultrasound- Guided Supraclavicular Block
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Ain Shams University · Academic / Other
- Sex
- All
- Age
- 25 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study to test efficacy of adding dexmedetomidine to articaine on sensory, motor and duration of analgesia during hemodialysis fistula creation under ultrasound guided supraclavicular block
Detailed description
Adult fifty patient with chronic renal failure on hemodialysis, scheduled for arteriovenous fistula creation under ultrasound guided supraclavicular block. Patients were randomly allocated in two group. The articaine group (group A) received 40 ml articaine hydrochloride 2% and articaine-dexmedetomidine group (group AD) received 40 ml. Of articaine 2% mixed with dexmedetomidine (1micogram/kg)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Articaine | Vial |
| DRUG | Dexmedetomidine | Vial |
Timeline
- Start date
- 2019-06-01
- Primary completion
- 2019-10-01
- Completion
- 2019-11-01
- First posted
- 2019-11-20
- Last updated
- 2019-11-20
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04171349. Inclusion in this directory is not an endorsement.